GILEAD SCIENCES, INC. Debt Securities, Available-for-sale, Noncurrent
GILEAD SCIENCES, INC. (GILD) had Debt Securities, Available-for-sale, Noncurrent of $20.48 billion as of 2016-12-31, per its 10-K filed 2017-02-27.
Discontinued › Balance Sheet › Assets › Assets, Noncurrent › Long-Term Investments
us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent · last filed 2017-02-27
- 2016-12-31: Debt Securities, Available-for-sale, Noncurrent $20.48B.
- 2016-09-30: Debt Securities, Available-for-sale, Noncurrent $19.34B.
- 2016-06-30: Debt Securities, Available-for-sale, Noncurrent $15.86B.
- 2016-03-31: Debt Securities, Available-for-sale, Noncurrent $13.00B.
| Period end | Debt Securities, Available-for-sale, Noncurrent |
|---|---|
| 2016-12-31 | $20.48B 10-K · filed 2017-02-27 |
| 2016-09-30 | $19.34B 10-Q · filed 2016-11-07 |
| 2016-06-30 | $15.86B 10-Q · filed 2016-08-05 |
| 2016-03-31 | $13.00B 10-Q · filed 2016-05-06 |
| 2015-12-31 | $11.60B 10-K · filed 2017-02-27 |
| 2015-09-30 | $9.40B 10-Q · filed 2015-11-04 |
| 2015-06-30 | $6.06B 10-Q · filed 2015-08-05 |
| 2015-03-31 | $3.22B 10-Q · filed 2015-05-08 |
| 2014-12-31 | $1.60B 10-Q · filed 2015-11-04 |
| 2014-09-30 | $1.38B 10-Q · filed 2014-11-05 |
| 2014-06-30 | $782.32M 10-Q · filed 2014-08-04 |
| 2014-03-31 | $389.87M 10-Q · filed 2014-05-07 |
| 2013-12-31 | $439.03M 10-Q · filed 2014-11-05 |
| 2013-09-30 | $665.06M 10-Q · filed 2013-10-31 |
| 2013-06-30 | $688.43M 10-Q · filed 2013-08-01 |
| 2012-12-31 | $719.84M 10-Q · filed 2013-10-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AMGEN INC (AMGN) | United States | $219.567B | 22.39 |
| Moderna, Inc. (MRNA) | United States | $77.819B | -8.86 |
| Revolution Medicines, Inc. (RVMD) | United States | $42.805B | -22.69 |
| BIOGEN INC. (BIIB) | United States | $33.427B | 19.60 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |